INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![GettyImages-950086574-oral-solid-OSD-pill-tablet-capsule-development]( "TPDs: Developing The Next Generation Of Oral Therapeutics")
TPDs: Developing The Next Generation Of Oral TherapeuticsTargeted Protein Degraders are a revolutionary drug class with challenges in bioavailability and formulation complexity. Strategic CDMO partnerships are key to successful, scalable development.
-
![GettyImages-2152658176 oncology, doctor, patient]( "How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology?")
How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology?By directing radioactive isotopes straight to diseased tissue, these agents deliver potent, localized treatment while sparing healthy cells — a major leap forward for patients with metastatic or treatment-resistant cancers.
-
![complex trials clear budgets thumb]( "Complex Trials, Clear Budgets: Global Clinical Trial Budgeting Strategies")
Complex Trials, Clear Budgets: Global Clinical Trial Budgeting StrategiesGain valuable insights into efficient budgeting strategies and discover how technology can offer a holistic solution for managing investigator grant costs.
-
![Clinical Leader Solutions Expo]( "Strategic Considerations For Oncology Trials In A Competitive Landscape")
Strategic Considerations For Oncology Trials In A Competitive LandscapeBy combining strategic foresight with hands-on support, the right partner accelerates oncology trial delivery and broadens access to promising therapies.
-
Site Perspectives On BYOD ePRO Use6/17/2024
This study examines participant convenience and compliance, aiming to understand and address the challenges faced by site personnel in global trials.
-
The Hidden Cost Of Preferred Vendors10/21/2025
Familiar vendors offer comfort — but at the cost of innovation, fit, and fresh thinking. Ease shouldn’t outweigh excellence when selecting partners for your clinical trial.
-
Meeting Eye Exam Needs At The Point Of Need3/11/2025
Learn more about how mobile vision clinics supported the staff at trial sites as well as the patients through the COVID-19 pandemic and beyond.
-
Stipends Create More Tax Burden — Here's A Better Option7/22/2025
Explore the tax reporting requirements, including the threshold for payments requiring a 1099 form rising from $600 to $2,000 in 2026.
-
Targeted Modalities: Trends, Challenges, CDMO Considerations8/11/2025
Targeted modalities are designed to bind specifically to receptors or biological targets, ensuring a more directed and effective treatment while reducing systemic exposure and unintended side-effects.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![doctor clinical trial meeting iStock-986569806]( "Full-Service Clinical Development Solutions")
Getting a novel therapy through the clinical development process to approval is complicated. Unearth how to advance novel medical therapies from Phase I-III clinical development to market with confidence.
-
![GettyImages-645455610 liver]( "Liver Disease CRO Services")
Biotechnology companies consider locations in the Asia-Pacific region, such as South Korea and China to access vast treatment-naïve patient populations and accelerate their clinical trials at lower costs.
-
![laptop document iStock-1188431918.jpg]( "Medical Writing And QC")
inSeption provides medical writing services as well as strategic submission planning expertise to ensure that your application is of the highest quality. Our highly experienced, fully dedicated team integrates with your organization to credibly manage the complexities of timeline creation and management, resourcing, document interdependencies, and transmission through the Electronic Submission Gateway (ESG).
-
![GettyImages-1319939893-car-travel-road]( "Greenphire Travel")
With dedicated coordinators and multilingual staff worldwide, Greenphire ensures smooth, compassionate travel experiences — removing barriers to participation and enhancing trial accessibility.
-
![GettyImages-1083316464_eye]( "Your Top Partner For Ophthalmic Drug Development")
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
